Good Data Science Practice: Moving Toward a Code of Practice for Drug Development-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Good Data Science Practice: Moving Toward a Code of Practice for Drug Development

Published:2022-05-16 Issue:1 Volume:15 Page:74-85
ISSN:1946-6315
Container-title:Statistics in Biopharmaceutical Research
language:en
Short-container-title:Statistics in Biopharmaceutical Research

Author:

Baillie Mark¹^ORCID,Moloney Conor²,Mueller Carsten Philipp³,Dorn Jonas⁴^ORCID,Branson Janice¹,Ohlssen David⁵

Affiliation:

1. Clinical Development & Analytics, Novartis Pharma AG, Basel, Switzerland

2. Clinical Development & Analytics, Novartis Pharma AG, Dublin, Ireland

3. Data & Digital, Beyond Conception GmbH, Altendorf, Switzerland

4. Roche Pharma Research and Early Development, pRED Informatics, Roche Innovation Center, Basel, Switzerland

5. Clinical Development & Analytics, Novartis Pharma AG, East Hannover, NJ

Publisher

Informa UK Limited

Subject

Pharmaceutical Science,Statistics and Probability

Link

https://www.tandfonline.com/doi/pdf/10.1080/19466315.2022.2063172

Reference106 articles.

1. Estimands in clinical trials - broadening the perspective

2. The scandal of poor medical research

3. Measurement in Medicine: The Analysis of Method Comparison Studies

4. Scientists rise up against statistical significance

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Medical Statistics in Drug Development and Regulatory Approval;Advances in Bioinformatics and Biomedical Engineering;2024-07-18

2. Predicting subgroup treatment effects for a new study: Motivations, results and learnings from running a data challenge in a pharmaceutical corporation;Pharmaceutical Statistics;2024-02-07

3. Methodology for Good Machine Learning with Multi‐Omics Data;Clinical Pharmacology & Therapeutics;2024-01-31

4. The Role of Statistical Thinking in Biopharmaceutical Research;Statistics in Biopharmaceutical Research;2023-07-03

5. Good Data Science Practice: Moving toward a Code of Practice for Drug Development (Rejoinder);Statistics in Biopharmaceutical Research;2023-01-02

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3